Home/Filings/4/0001790340-26-000008
4//SEC Filing

Feinberg Peter 4

Accession 0001790340-26-000008

CIK 0001790340other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 8:10 AM ET

Size

7.2 KB

Accession

0001790340-26-000008

Insider Transaction Report

Form 4
Period: 2026-01-12
Transactions
  • Purchase

    Class A Common Stock

    [F1]
    2026-01-12$4.35/sh+20,000$86,904135,441 total(indirect: By LLC)
Holdings
  • Class A Common Stock

    156,766
  • Class A Common Stock

    (indirect: General Partner of PF Associates L.P.)
    392,242
  • Class A Common Stock

    (indirect: By LLC)
    476,615
Footnotes (1)
  • [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.315 to $4.38. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg|2026-01-14

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001870076

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 8:10 AM ET
Size
7.2 KB